Tuesday, September 20, 2016

BRIEF-Lannett announces approval for Buprenorphine and Naloxone Sublingual Tablets

* Received approval from FDA of ANDA for Buprenorphine and

Naloxone Sublingual Tablets, 2 mg/0.5 mg and 8 mg/2 mg

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)